IFNG and glioblastoma: CAR T cells that secrete checkpoint inhibitors are not only as efficacious in slowing GBM growth in murine model as co-administration of the checkpoint inhibitor, but they also have more specific targeting, as seen by increased IFN gamma and TNF alpha secretion.